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Hypertension (HTN) is an important clinical problem affecting nearly 80 million people in 
the United States.1 Despite the recognized importance of blood pressure (BP) control for 
those with HTN, only 54% of patients with HTN seen in primary care have their BP 
controlled (defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg).1 Blood 
pressure measurement error (including inappropriate cuff size, talking during measurement, 
terminal digit preference, and incorrect arm and body positioning) is a major cause of poor 
BP control2 and reducing measurement error has the potential to avoid overtreatment. The 
American Heart Association recommends repeating a BP measurement at the same clinic 
visit with at least 1 minute separating BP readings,2 yet in busy primary care practices BP 
often is measured only once. We evaluated the effect of a second BP measurement on the 
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rate of BP control among more than 38000 patients with diagnosed HTN and followed in 
primary care.
Methods
MetroHealth granted institutional review board approval and waived the requirement for 
written informed consent. As part of ongoing quality improvement, we introduced an 
advisory alert into our electronic health record (EHR) to remind staff to remeasure the BP 
when the initial BP was elevated (≥140/90 mm Hg). To assess the association of repeated BP 
measurement with BP control, we queried the EHR to obtain all recorded BP values for 
patients with a problem list diagnosis of HTN who were seen in a primary care clinic 
between January 1 and December 31, 2016, at MetroHealth, an urban safety-net system in 
Cleveland, Ohio. Our primary outcomes were (1) the change in systolic BP (final minus 
initial reading) among patients with an initially elevated BP (≥140/90 mm Hg) who had a 
repeated measurement during the same visit and (2) the proportion of patients whose BP was 
controlled on the final reading overall and stratified by initial systolic BP level. We also 
assessed the contribution of regression to the mean3 to the systolic BP change.
Results
During the study period, 38 260 patients with HTN made 80 864 primary care office visits. 
The mean age was 61 years, 22 623 (59%)were female, 16 301 (43%)were black, and 10 
340 (27%) were on Medicaid and 2105 (6%) were uninsured. The initial BP was at least 
140/90 mm Hg at 31 531 visits (39%) and an initially elevated BP was remeasured at 26089 
visits (83%). The median change (final minus initial reading) in systolic BP was −8 mm Hg 
(interquartile range, 2–17 mm Hg). The change in systolic BP was positively associated with 
the initial BP value; the higher the initial systolic BP, the greater the change in final systolic 
BP (Figure 1). Among all patients with a repeated BP measurement, 9358 (36%) of final BP 
readings were lower than 140/90 mmHg, with those closest to the threshold more likely to 
be controlled on repeated measurement (Figure 2). Overall, repeated measurement of an 
initially elevated BP was associated with increased HTN control rate from 61%to 73%. The 
estimated effect of regression to the mean was 6.1 mm Hg, accounting for nearly 65%of the 
mean observed decrease in systolic BP.
Discussion
Among a large sample of patients with HTN, repeated measurement of an initially elevated 
BP was associated with a median of 8 mm Hg improvement in systolic BP. Our result agrees 
with the 11 mm Hg-decrease recently described in a sample of 73 primary care patients.4 
While much of the change in systolic BP may be attributed to regression to the mean, the 
observed decrease remains clinically important, comparable with that associated with 
addition of an antihypertensive medication.5 As the health care system moves toward value-
based care initiatives, such as accountable care organizations and shared savings programs, 
implementing routine repeated measurement for an initially elevated BP may contribute to 
improved decision making around HTN management and should be considered a standard 
component of programs to improve BP control.
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Figure 1. Median Change in Systolic Blood Pressure (BP) by Subgroup
Boxes show the median as the line across the middle and the 25th and 75th percentiles as 
ends. Lines represent the 25th percentiles − 1.5 × (75th − 25th percentile) and the 75th 
percentile +1.5 × (75th − 25th percentiles). Dots represent observations that were outliers.
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Figure 2. Proportion of Visits in Which Initially Elevated Blood Pressure (BP)Was Controlled on 
Repeated Measurement by Initial Systolic BP (in mm Hg)
Error bars indicate 95%CIs.
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